We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of bulk actives, formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company also provides anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.
TODAY'S HIGH
314
TODAY'S LOW
285.75
52 WEEK HIGH
1525
52 WEEK LOW
265
% of Shares Held by
All Insider
91.73%
% of Shares Held by
Institutions
2.45%
% of Float Held by
Institutions
29.64%
Number of Institutions
Holding Shares
1
MARKET CAP
1256.32 Cr.
ETERPRISE VALUE
1575.15 Cr.
NO. OF SHARES
4.08 Cr.
BOOK VALUE
164.899
DIV. YIELD
3%
DEBT
301.35 Cr.
GROSS PROFIT
0
CASH
20.57 Cr.
REVENUE
500.98 Cr.
REVENUE/SHARE
123.103
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | 66.85 Cr. | 147.17 Cr. | 37.22 Cr. |
| Change To Liabilities | 0 | 17.93 Cr. | 7.69 Cr. | -57.67 Cr. |
| Total cashflows from Investing Activities | 0 | 67.20 Cr. | 167.11 Cr. | 45.47 Cr. |
| Net Borrowings | 0 | -125.08 Cr. | -290 Cr. | -290 Cr. |
| Total Cash from Financing Activities | 0 | -164.98 Cr. | -250.33 Cr. | -29.96 Lakhs |
| Other Liabilities | 0 | 60.63 Cr. | -3.88 Cr. | -67.58 Cr. |
| Total Assets | 0 | 0 | 40 Cr. | 40 Cr. |
| Net Income | 0 | -116.53 Cr. | -131.07 Cr. | 69.40 Cr. |
| Change in Cash | 0 | -74.19 Cr. | -2.41 Cr. | 57.19 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 0 | 23.58 Cr. | 80.80 Cr. | 12.02 Cr. |
| Depreciation | 0 | 108.88 Cr. | 117.90 Cr. | 127.72 Cr. |
| Other Cashflows from Investing Activities | 0 | 67.07 Lakhs | 24.17 Cr. | 14.86 Cr. |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | 0 | -33.49 Cr. | 14.06 Cr. | 23.96 Cr. |
| Change to Account Receivables | 0 | -82.02 Cr. | 44.01 Cr. | -9.14 Cr. |
| Other Cashflows from Financing Activities | 0 | -39.90 Cr. | -32.53 Lakhs | -29.96 Lakhs |
| Change to Net Income | 0 | 68.15 Cr. | 32.06 Cr. | -76.88 Cr. |
| Capital Expenditures | 0 | -60.40 Lakhs | -4.24 Cr. | -6.62 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 0 | -95.24 Cr. | -69.69 Cr. | 69.40 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 0 | -50.57 Cr. | -72.17 Cr. | -80.04 Cr. |
| Selling General Administrative | 0 | 68.61 Cr. | 86.34 Cr. | 94.49 Cr. |
| Gross Profit | 0 | 208.76 Cr. | 259.80 Cr. | 307.40 Cr. |
| Ebit | 0 | -50.57 Cr. | -72.17 Cr. | -80.04 Cr. |
| Operating Income | 0 | -50.57 Cr. | -72.17 Cr. | -80.04 Cr. |
| Other Operating Expenses | 0 | 81.80 Cr. | 127.70 Cr. | 163.01 Cr. |
| Interest Expense | 0 | -51.33 Cr. | -4.15 Cr. | -29.96 Lakhs |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Total Revenue | 0 | 450.06 Cr. | 483.80 Cr. | 599.98 Cr. |
| Total Operating Expenses | 0 | 500.63 Cr. | 555.97 Cr. | 680.02 Cr. |
| Cost of Revenue | 0 | 241.29 Cr. | 224 Cr. | 292.57 Cr. |
| Total Other Income Expense Net | 0 | -44.67 Cr. | 2.48 Cr. | 149.45 Cr. |
| Discontinued Operations | 0 | -21.28 Cr. | -61.37 Cr. | -61.37 Cr. |
| Net Income from Continuous Ops. | 0 | -95.24 Cr. | -69.69 Cr. | 69.40 Cr. |
| Net Income Applicable to Common Shares | 0 | -116.53 Cr. | -131.07 Cr. | 69.40 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 0 | 36.86 Lakhs | 24.77 Cr. | 35.15 Cr. |
| Capital Surplus | 0 | 464.47 Cr. | 464.47 Cr. | 464.47 Cr. |
| Total Liabilities | 0 | 584.34 Cr. | 693.92 Cr. | 3781.07 Cr. |
| Stock Holder Equity | 0 | 652.90 Cr. | 765.98 Cr. | -704.03 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 2.56 Cr. | 1.46 Cr. | 13.04 Cr. |
| Total Assets | 0 | 1237.25 Cr. | 1459.90 Cr. | 3077.03 Cr. |
| Common Stock | 0 | 40.81 Cr. | 40.81 Cr. | 88.96 Cr. |
| Retained Earnings | 0 | -1471.65 Cr. | -1355.72 Cr. | -1311.32 Cr. |
| Other Liabilities | 0 | 14.76 Cr. | 15.01 Cr. | 10.92 Cr. |
| Good Will | 0 | 0 | 0 | 94.82 Cr. |
| Treasury Stock | 0 | 1619.26 Cr. | 1616.41 Cr. | 53.84 Cr. |
| Other Assets | 0 | 9.10 Cr. | 6.69 Cr. | 774.68 Cr. |
| Cash | 0 | 15.69 Cr. | 89.89 Cr. | 92.31 Cr. |
| Current Liabilities | 0 | 142.08 Cr. | 174.93 Cr. | 2345.54 Cr. |
| Long Term Asset Charges | 0 | 0 | 0 | 0 |
| Short Long Term Debt | 0 | 22.40 Cr. | 62.42 Cr. | 1109.85 Cr. |
| Other Stockholder Equity | 0 | 1619.26 Cr. | 1616.41 Cr. | 53.84 Cr. |
| Property Plant Equipment | 0 | 677.50 Cr. | 858.77 Cr. | 1404.44 Cr. |
| Total Cur. Assets | 0 | 549.85 Cr. | 569.32 Cr. | 767.46 Cr. |
| Long Term Investments | 0 | 41.77 Lakhs | 33.82 Lakhs | 47.21 Lakhs |
| Net Tangible Assets | 0 | 652.53 Cr. | 741.21 Cr. | -834.01 Cr. |
| Short Term Investments | 0 | 80 Lakhs | 1.22 Lakhs | 233.20 Cr. |
| Net Receivables | 0 | 135.76 Cr. | 67.97 Cr. | 122.26 Cr. |
| Long Term Debt | 0 | 427.49 Cr. | 503.97 Cr. | 1424.60 Cr. |
| Inventory | 0 | 152.88 Cr. | 141.69 Cr. | 169.77 Cr. |
| Accounts Payable | 0 | 109.95 Cr. | 101.58 Cr. | 302.44 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account